Charles River Laboratories International, Inc. (NYSE:CRL) Receives $246.54 Average Target Price from Analysts
Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are currently covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month […]
More Stories
Astika Holdings, Inc. (OTCMKTS:ASKH) Short Interest Update
Astika Holdings, Inc. (OTCMKTS:ASKH – Get Free Report) was the recipient of a significant drop in short interest during the...
RTX Co. (NYSE:RTX) Shares Bought by Quest Partners LLC
Quest Partners LLC boosted its position in shares of RTX Co. (NYSE:RTX – Free Report) by 8,216.2% during the 3rd...
Sirius Real Estate Limited (LON:SRE) Declares Dividend of €0.03
Sirius Real Estate Limited (LON:SRE – Get Free Report) declared a dividend on Monday, November 18th,Upcoming Dividends.Co.Uk reports. Shareholders of...
Vaughan Nelson Investment Management L.P. Sells 157 Shares of AMETEK, Inc. (NYSE:AME)
Vaughan Nelson Investment Management L.P. decreased its position in AMETEK, Inc. (NYSE:AME – Free Report) by 0.1% in the 3rd...
Sutro Biopharma (NASDAQ:STRO) Given Buy Rating at HC Wainwright
Sutro Biopharma (NASDAQ:STRO – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in...
Bank of America Issues Pessimistic Forecast for PepGen (NASDAQ:PEPG) Stock Price
PepGen (NASDAQ:PEPG – Get Free Report) had its target price lowered by equities researchers at Bank of America from $10.00...